| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA
2 Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA; Department of Anesthesiology, University of North Carolina, Houston, TX, USA
3 Methodist Hospital-Debakey Heart Center, Baylor College of Medicine, Houston, TX, USA
4 Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA; Departments of Medicine, Pharmacology, and Cell and Developmental Biology, University of North Carolina, Chaple Hill, NC, USA
* To whom correspondence should be addressed. E-mail: cpatters{at}med.unc.edu.
Limitation of damage after ischemia and reperfusion injury to the myocardium remains an elusive clinical goal. Previous studies have suggested that molecular chaperones, which include members of the heat shock protein family, may have cardioprotective effects, although the protective role of endogenous chaperones has not been well documented. CHIP (carboxyl terminus of Hsp70-interacting protein) is a co-chaperone/ubiquitin ligase that integrates the response to stress at multiple levels. We tested the response of CHIP -/- mice to in vivo ischemia and reperfusion injury induced by left anterior descending coronary artery ligation. Compared with wild-type littermates, CHIP -/- mice had decreased survival and increased incidence of arrhythmias during reperfusion. The size of myocardial infarction, as assessed by the ratio of infarct area to area at risk, was 50% greater in CHIP -/- mice. Increased infarct size was accompanied by impaired upregulation of the chaperone Hsp70 after ischemia/reperfusion injury. In situ analysis also indicated that hearts of CHIP -/- mice were more prone to develop apoptosis in cardiomyocytes and especially endothelial cells of intramural vessels. Previous studies have found that CHIP plays a central role in maintaining protein quality control and coordinating the response to stress. The present data indicate that these functions of CHIP provide a critical cardioprotective effect in the setting of ischemia/reperfusion injury, due in part to increased apoptosis in cardiac cells. Quality control mechanisms may therefore be underappreciated clinical targets for maximizing myocardial protection after injury.
This article has been cited by other articles:
|
|
 |
|
  X. Yu and D. C. Kem Proteasome inhibition during myocardial infarction Cardiovasc Res, October 4, 2009; (2009) cvp309v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Su and X. Wang The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective Cardiovasc Res, September 16, 2009; (2009) cvp287v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. McDonough, P. C. Charles, E. G. Hilliard, S.-b. Qian, J.-N. Min, A. Portbury, D. M. Cyr, and C. Patterson Stress-dependent Daxx-CHIP Interaction Suppresses the p53 Apoptotic Program J. Biol. Chem., July 31, 2009; 284(31): 20649 - 20659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Li, P. Xie, Y. Fan, H. Zhang, L. Zheng, D. Gu, C. Patterson, and H. Li C Terminus of Hsc70-interacting Protein Promotes Smooth Muscle Cell Proliferation and Survival through Ubiquitin-mediated Degradation of FoxO1 J. Biol. Chem., July 24, 2009; 284(30): 20090 - 20098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Willis, J. C. Schisler, A. L. Portbury, and C. Patterson Build it up-Tear it down: protein quality control in the cardiac sarcomere Cardiovasc Res, February 15, 2009; 81(3): 439 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-N. Min, R. A. Whaley, N. E. Sharpless, P. Lockyer, A. L. Portbury, and C. Patterson CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality Control Mol. Cell. Biol., June 15, 2008; 28(12): 4018 - 4025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Moss, W. E. Stansfield, M. S. Willis, R.-H. Tang, and C. H. Selzman IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2248 - H2253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Herrmann, L. O. Lerman, and A. Lerman Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation Circ. Res., May 11, 2007; 100(9): 1276 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Willis, C. Ike, L. Li, D.-Z. Wang, D. J. Glass, and C. Patterson Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo Circ. Res., March 2, 2007; 100(4): 456 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang and J. Robbins Heart Failure and Protein Quality Control Circ. Res., December 8, 2006; 99(12): 1315 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, C. Schenke, and A. Sarikas The ubiquitin-proteasome system: Focus on the heart Cardiovasc Res, June 1, 2006; 70(3): 410 - 421. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
